Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

300015 Aier Eye Hospital Group

Watchlist
32.160
+0.020+0.06%
Market Close  02/07 15:00 CCT
High
32.650
Open
32.300
Turnover
801.24M
Low
31.980
Pre Close
32.140
Volume
248.18Klot
Market Cap
230.80B
P/E(TTM)
86.22
52wk High
35.169
Shares
7.18B
P/E(Static)
99.26
52wk Low
19.167
Float Cap
186.62B
Bid/Ask %
36.21%
Historical High
55.536
Shs Float
5.80B
Volume Ratio
0.67
Historical Low
0.327
Dividend TTM
0.092
Div Yield TTM
--
P/B
14.22
Dividend LFY
0.29%
Div Yield LFY
--
Turnover Ratio
0.43%
Amplitude
2.09%
Avg Price
32.284
Lot Size
100
Float Cap
186.62B
Bid/Ask %
36.21%
Historical High
55.536
Shs Float
5.80B
Volume Ratio
0.67
Historical Low
0.327
Dividend TTM
0.092
Limit Up
38.570
P/B
14.22
Dividend LFY
0.29%
Limit Down
25.710
Turnover Ratio
0.43%
Amplitude
2.09%
Avg Price
32.284
Lot Size
100
Ask
125.55Klot
Bid
115.39Klot
Price Forecast

News

Comment

Sign in to post a comment

    No comment yet

    Company Overview More
    The company is a well-known global chain of ophthalmology medical institutions and an IPO-listed medical institution (stock code: 300015, selected as a stock in the Shanghai and Shenzhen 300 Index in 2015). As of 2019, more than 300 specialized ophthalmology hospitals have been established in 30 provinces and cities in mainland China, covering more than 70% of the country's health insurance population and the annual number of outpatients exceeding 6.5 million people. Furthermore, there are more than 80 eye hospitals in the US, Europe, and Hong Kong, China. As a professional ophthalmology chain, the company is mainly engaged in the diagnosis and treatment of various ophthalmologic diseases, surgical services and medical optometry. Currently, the medical network has spread across mainland China, Hong Kong, Europe, the United States, and Southeast Asia, setting a strategic pattern for global development. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of various ophthalmologic diseases, surgical services and medical optometry accessories. Honors received include Aer Ophthalmology winning the “Top Ten Listed Companies Most Respected by Investors” in China, Aer Ophthalmology receiving the Best Value for Continued Investment Award, the Most Influential Listed Company Leader Award, the Gold Medal Director's Award, and Aer Ophthalmology's 2017 Best Shareholder Return Award for Listed Companies in China.
    CEO: --
    Market: --
    Listing Date: 10/30/2009
    Paper Trade More
    Direction
    Buy
    Sell
    Types
    LMT Order
    Price
    QTY
    Amount
    --
    Hot List
    TradeSearchNews
    SymbolLatest price%Chg

    Loading...

    Watchlist